Two neuronal peptides encoded from a single transcript regulate mitochondrial complex III in Drosophila

  1. Justin A Bosch  Is a corresponding author
  2. Berrak Ugur
  3. Israel Pichardo-Casas
  4. Jordan Rabasco
  5. Felipe Escobedo
  6. Zhongyuan Zuo
  7. Ben Brown
  8. Susan Celniker
  9. David A Sinclair
  10. Hugo J Bellen
  11. Norbert Perrimon  Is a corresponding author
  1. Harvard University, United States
  2. Howard Hughes Medical Institute, Yale University, United States
  3. Baylor College of Medicine, United States
  4. Lawrence Berkeley National Laboratory, United States

Abstract

Naturally produced peptides (<100 amino acids) are important regulators of physiology, development, and metabolism. Recent studies have predicted that thousands of peptides may be translated from transcripts containing small open reading frames (smORFs). Here, we describe two peptides in Drosophila encoded by conserved smORFs, Sloth1 and Sloth2. These peptides are translated from the same bicistronic transcript and share sequence similarities, suggesting that they encode paralogs. Yet, Sloth1 and Sloth2 are not functionally redundant, and loss of either peptide causes animal lethality, reduced neuronal function, impaired mitochondrial function, and neurodegeneration. We provide evidence that Sloth1/2 are highly expressed in neurons, imported to mitochondria, and regulate mitochondrial complex III assembly. These results suggest that phenotypic analysis of smORF genes in Drosophila can provide a wealth of information on the biological functions of this poorly characterized class of genes.

Data availability

The current manuscript did not generate any datasets. Raw gel and western image source files are present in Supplemental File 4, which can be downloaded at:https://doi.org/10.5061/dryad.83bk3j9vc

The following data sets were generated

Article and author information

Author details

  1. Justin A Bosch

    Department of Genetics, Harvard University, Boston, United States
    For correspondence
    jabosch@hms.harvard.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8499-1566
  2. Berrak Ugur

    Department of Neuroscience, Howard Hughes Medical Institute, Yale University, New Haven, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4806-8891
  3. Israel Pichardo-Casas

    Department of Genetics, Harvard University, Boston, United States
    Competing interests
    No competing interests declared.
  4. Jordan Rabasco

    Department of Genetics, Harvard University, Boston, United States
    Competing interests
    No competing interests declared.
  5. Felipe Escobedo

    Department of Genetics, Harvard University, Boston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6830-9210
  6. Zhongyuan Zuo

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    No competing interests declared.
  7. Ben Brown

    Biological Systems and Engineering, Lawrence Berkeley National Laboratory, Berkeley, United States
    Competing interests
    No competing interests declared.
  8. Susan Celniker

    Biological Systems and Engineering, Lawrence Berkeley National Laboratory, Berkeley, United States
    Competing interests
    No competing interests declared.
  9. David A Sinclair

    Department of Genetics, Harvard University, Boston, United States
    Competing interests
    No competing interests declared.
  10. Hugo J Bellen

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    Hugo J Bellen, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5992-5989
  11. Norbert Perrimon

    Department of Genetics, Harvard University, Boston, United States
    For correspondence
    perrimon@genetics.med.harvard.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7542-472X

Funding

Damon Runyon Foundation

  • Justin A Bosch

National Institutes of Health (R01GM084947)

  • Susan Celniker

National Institutes of Health (R01GM067761)

  • Susan Celniker

National Institutes of Health (R24OD019847)

  • Susan Celniker

National Institutes of Health (NHGRI HG009352)

  • Susan Celniker

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Agnieszka Chacinska, IMol Polish Academy of Sciences, Poland

Publication history

  1. Preprint posted: July 2, 2020 (view preprint)
  2. Received: August 15, 2022
  3. Accepted: November 1, 2022
  4. Accepted Manuscript published: November 8, 2022 (version 1)
  5. Version of Record published: November 22, 2022 (version 2)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 1,570
    Page views
  • 290
    Downloads
  • 2
    Citations

Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Justin A Bosch
  2. Berrak Ugur
  3. Israel Pichardo-Casas
  4. Jordan Rabasco
  5. Felipe Escobedo
  6. Zhongyuan Zuo
  7. Ben Brown
  8. Susan Celniker
  9. David A Sinclair
  10. Hugo J Bellen
  11. Norbert Perrimon
(2022)
Two neuronal peptides encoded from a single transcript regulate mitochondrial complex III in Drosophila
eLife 11:e82709.
https://doi.org/10.7554/eLife.82709

Further reading

    1. Developmental Biology
    2. Genetics and Genomics
    Mahdi Moradi Marjaneh, Edwin P Kirk ... Richard P Harvey
    Research Article

    Unlike single-gene mutations leading to Mendelian conditions, common human diseases are likely to be emergent phenomena arising from multilayer, multiscale and highly interconnected interactions. Atrial and ventricular septal defects are the most common forms of cardiac congenital anomalies in humans. Atrial septal defects (ASD) show an open communication between left and right atria postnatally, potentially resulting in serious hemodynamic consequences if untreated. A milder form of atrial septal defect, patent foramen ovale (PFO), exists in about one quarter of the human population, strongly associated with ischaemic stroke and migraine. The anatomic liabilities and genetic and molecular basis of atrial septal defects remain unclear. Here, we advance our previous analysis of atrial septal variation through quantitative trait locus (QTL) mapping of an advanced intercross line (AIL) established between the inbred QSi5 and 129T2/SvEms mouse strains, that show extremes of septal phenotypes. Analysis resolved 37 unique septal QTL with high overlap between QTL for distinct septal traits and PFO as a binary trait. Whole genome sequencing of parental strains and filtering identified predicted functional variants, including in known human congenital heart disease genes. Transcriptome analysis of developing septa revealed downregulation of networks involving ribosome, nucleosome, mitochondrial and extracellular matrix biosynthesis in the 129T2/SvEms strain, potentially reflecting an essential role for growth and cellular maturation in septal development. Analysis of variant architecture across different gene features, including enhancers and promoters, provided evidence for involvement of non-coding as well as protein coding variants. Our study provides the first high resolution picture of genetic complexity and network liability underlying common congenital heart disease, with relevance to human ASD and PFO.

    1. Genetics and Genomics
    Xiaozhen Liu, Jing Qiao ... Liping Yang
    Research Article

    Mutant RHO is the most frequent genetic cause of autosomal dominant retinitis pigmentosa. Here, we developed an allele-specific gene editing therapeutic drug to selectively target the human T17M RHO mutant allele while leaving the wild-type RHO allele intact for the first time. We identified a Staphylococcus aureus Cas9 (SaCas9) guide RNA that was highly active and specific to the human T17M RHO allele. In vitro experiments using HEK293T cells and patient-specific induced pluripotent stem cells (iPSCs) demonstrated active nuclease activity and high specificity. Subretinal delivery of a single adeno-associated virus serotype 2/8 packaging SaCas9 and sgRNA to the retinas of the RHO humanized mice showed that this therapeutic drug targeted the mutant allele selectively, thereby downregulating the mutant RHO mRNA expression. Administration of this therapeutic drug resulted in a long-term (up to 11 months after treatment) improvement of retinal function and preservation of photoreceptors in the mutant humanized heterozygous mice. Our study demonstrated a dose-dependent therapeutic effect in vivo. Unwanted off-target effects were not observed at the whole-genome sequencing level. Our study provides strong support for the further development of this effective therapeutic drug to treat RHO-T17M associated autosomal dominant retinitis pigmentosa (adRP), also offers a generalizable framework for developing gene editing medicine. Furthermore, our success in restoring the vision loss in the suffering RHO humanized mice verifies the feasibility of allele-specific CRISPR/Cas9-based medicines for other autosomal dominant inherited retinal dystrophies.